| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/07/1998 | CA2202345A1 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cox-2 |
| 09/06/1998 | CA2199325A1 Cyclic analogs of pth and pthrp |
| 09/05/1998 | CA2230965A1 New benzoxazinedione derivatives, a method of producing them and the use thereof |
| 09/03/1998 | WO1998038320A1 Component of bromelain |
| 09/03/1998 | WO1998038319A1 Component of bromelain |
| 09/03/1998 | WO1998038317A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | WO1998038309A1 Clavaspirins |
| 09/03/1998 | WO1998038291A1 Component of bromelain |
| 09/03/1998 | WO1998038218A1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 09/03/1998 | WO1998038212A2 Chimeric polypeptides containing chemokine domains |
| 09/03/1998 | WO1998038194A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 09/03/1998 | WO1998038189A1 Oxazolidines as 5-ht2a-antagonists |
| 09/03/1998 | WO1998038187A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 09/03/1998 | WO1998038186A1 Quinoxalinediones |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | WO1998038173A1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 09/03/1998 | WO1998038167A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 09/03/1998 | WO1998038165A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 09/03/1998 | WO1998037918A1 Staphylococcus 3-dehydroquinate synthase |
| 09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | WO1998037896A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | WO1998037894A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 09/03/1998 | WO1998037892A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
| 09/03/1998 | WO1998037885A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 09/03/1998 | WO1998037883A1 Forskohlin for promoting lean body mass |
| 09/03/1998 | WO1998037882A1 Method of using neurotrophic carbamates and ureas |
| 09/03/1998 | WO1998037880A1 Inhibitors of leaderless protein export |
| 09/03/1998 | WO1998037873A2 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid |
| 09/03/1998 | WO1998024804A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/03/1998 | WO1998008855A3 N6 heterocyclic substituted adenosine derivatives |
| 09/03/1998 | CA2282707A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | CA2282639A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | CA2281925A1 Inhibitors of leaderless protein export |
| 09/03/1998 | CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | CA2281096A1 Method of using neurotrophic carbamates and ureas |
| 09/03/1998 | CA2280855A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
| 09/03/1998 | CA2279887A1 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid |
| 09/03/1998 | CA2198988A1 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861837A1 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/02/1998 | EP0861666A2 Pharmaceutical composition for use in treatment of diabetes |
| 09/02/1998 | EP0861663A2 Osteoclastgenic inhibitory agent comprising interleukin-18 |
| 09/02/1998 | EP0861329A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861257A1 Spiro piperidine derivatives as 5mt receptor antagonists |
| 09/02/1998 | EP0861253A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/02/1998 | EP0861251A1 Morpholine derivatives and their use as therapeutic agents |
| 09/02/1998 | EP0861247A1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 09/02/1998 | EP0861246A1 Prolylendopeptidase inhibitors |
| 09/02/1998 | EP0861243A1 Heterocyclic compounds as bradykinin antagonists |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861236A1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 09/02/1998 | EP0861235A1 Substituted benzylaminopiperidine compounds |
| 09/02/1998 | EP0861234A1 Enantiomers of cis-benz e]indole compounds, their preparation and utility as dopamine-d3 receptor selective agents |
| 09/02/1998 | EP0861231A1 L-n?6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 09/02/1998 | EP0861226A1 Synthesis of carboxylic acid derivatives |
| 09/02/1998 | EP0861087A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 09/02/1998 | EP0861086A1 Type ix collagen and chimeras |
| 09/02/1998 | EP0861078A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0861071A1 Benzamidoxime prodrugs as antipneumocystic agents |
| 09/02/1998 | EP0861070A2 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 09/02/1998 | EP0861030A1 Hemoregulatory compounds |
| 09/02/1998 | EP0686044B1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/02/1998 | EP0426785B1 Compositions and methods for treating viral infections |
| 09/02/1998 | CN1192240A Recombinant mistletoe lectin (rML) |
| 09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
| 09/02/1998 | CN1192207A 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192206A Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192205A Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192204A 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors |
| 09/02/1998 | CN1192201A N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1192146A 4,4-(disubstituted) cyclohexan-1-ols)-monomers and related compounds |
| 09/02/1998 | CN1192145A Methods for minimizing bone loss |
| 09/02/1998 | CN1192121A Modulation of calcium channels |
| 09/02/1998 | CN1191862A 8-substituted-1,3,8-triaza-spiro £4,5| decan-4-on derivatives |
| 09/02/1998 | CN1191750A Externally used medicine for fishes |
| 09/01/1998 | US5801256 Method for the synthesis of 8-C-β-D 2'-O-(E)-cinnamoyl!glycopyranosyl-2- 2-hydroxy!propyl-7-methoxy-5-methylchromone |
| 09/01/1998 | US5801253 Retinoic acid X-receptor ligands |
| 09/01/1998 | US5801229 Radiation sensitizers; antitumor agents |
| 09/01/1998 | US5801199 Pharmaceutical composition for treating acute rhinitis |
| 09/01/1998 | US5801195 Immunotherapeutic aryl amides |
| 09/01/1998 | US5801183 Heterocyclc alcohols for nervous system disorders |
| 09/01/1998 | US5801180 Antiischemic agents and cardiovascular disorders |
| 09/01/1998 | US5801148 Serine protease inhibitors-proline analogs |
| 09/01/1998 | US5801044 Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions |
| 09/01/1998 | US5801017 Production of recombinant factor Xa inhibitor of leech Hirudo medicinalis |
| 09/01/1998 | US5801014 Growth differentiation factor-5 |
| 09/01/1998 | US5801005 Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| 09/01/1998 | US5800988 Cdna libraries with nucleotide sequences coded for immunoglobulins with polypeptide chains |
| 09/01/1998 | US5800808 Copolymer-1 improvements in compositions of copolymers |
| 09/01/1998 | US5800596 Water-in-oil emulsion containing retinol, its use and its packaging |
| 09/01/1998 | CA1340023C Tetrapyrrole aminocarboxylic acids |
| 08/28/1998 | CA2229707A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 08/27/1998 | WO1998037218A1 Hydroxyazepanes as inhibitors of glycosidase and hiv protease |
| 08/27/1998 | WO1998037195A1 Morphogenic proteins |
| 08/27/1998 | WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 08/27/1998 | WO1998037099A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |